CCL17 deficiency has been reported to potentially prolong cardiac graft survival (Alferink et al., 2003) and improve the symptoms of central nervous system diseases (Fulle et al., 2018; Scheu et al., 2017). The gene discussed is CCL17; the disease is central nervous system disorder.